- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01261676
Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care (SIMPLE)
Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care.
Caesarean (CS) delivery rates in the Netherlands increased from 5 to 15% the last 20 years. CSs have no clear benefit for overall neonatal outcome and are associated with higher maternal complications and high costs. Dutch guidelines offer clear recommendations on factors that have a direct effect on the decision to perform a CS.
Hypothesis: there is incomplete adherence to the recommendations from the guidelines on CS among Dutch gynaecologists.
This study consists of four phases:
- Development of quality indicators: A set of quality indicators regarding the process, structure and outcome of care will be developed according to the RAND-modified Delphi method. A representative, national expert panel consisting of 12 to 15 obstetricians and midwives will participate.
- Current care study: The current Dutch care will be studied in 20 hospitals (N=80 gynaecologists). 1000 files on performed CSs are analyzed regarding the adherence to the developed quality indicators. To get insight into Dutch practices compared to international data, basic obstetrical data will be extracted from the delivery database.
- Barrier analysis: A barrier analysis will be carried out based on the results of the current care study. Two groups of hospitals will be identified in the upper and lower extremes of the 'adherence distribution': 5 hospitals with the lowest and 5 hospitals with the highest adherence scores. Factors that determine the decision to perform a CS or not (barriers and facilitators) will be analyzed in both groups using semi-structured interviews among 15-20 professionals and 15-20 patients. A questionnaire will be used to study the 'prevalence' of these factors among all obstetric gynaecologists in the Netherlands and among 200 patients.
- Controlled before- and-after (CBA) study: Based on the outcomes of the current care study and the barrier analysis, a tailor made implementation strategy will be developed in order to increase adherence to the CS quality indicators. Target groups will be selected with focus on women with both a high incidence of the indicator and low indicator adherence. The strategy will be executed and evaluated in a CBA-study in 12 hospitals (6 intervention, 6 control) in terms of effectiveness, experiences and costs. The sample size will be dependent on the target group and adherence to the quality indicators regarding this target group. These data will be available after performing the current care and the barrier study.
Study Overview
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Almelo, Netherlands
- Ziekenhuisgroep Twente
-
Almere, Netherlands
- Flevo ziekenhuis
-
Amersfoort, Netherlands
- Meander Medisch Centrum
-
Amsterdam, Netherlands
- Academisch Medisch Centrum
-
Apeldoorn, Netherlands
- Gelreziekenhuizen
-
Arnhem, Netherlands
- Rijnstate Ziekenhuis
-
Capelle aan den Ijjsel, Netherlands
- IJsselland ziekenhuis
-
Eindhoven, Netherlands
- Catharina-ziekenhuis
-
Groningen, Netherlands
- University Medical Centre Groningen
-
Hardenberg, Netherlands
- Ropcke-Zweers Ziekenhuis
-
Heerlen, Netherlands
- Atrium Medisch Centrum Parkstad
-
Helmond, Netherlands
- Elkerliek Ziekenhuis
-
Hilversum, Netherlands
- Tergooiziekenhuizen
-
Maastricht, Netherlands
- Maastricht Universitair Medisch Centrum
-
Nijmegen, Netherlands
- Universitair Medisch Centrum St. Radboud
-
Sittard, Netherlands
- Orbis Medisch Centrum
-
Utrecht, Netherlands
- Universitair Medisch Centrum Utrecht
-
Veldhoven, Netherlands
- Máxima Medisch Centrum
-
Weert, Netherlands
- Sint Jansgasthuis
-
Zaandam, Netherlands
- Zaans Medisch Centrum
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- Development of quality indicators: 12-15 obstetricians and midwives
- Current care study: All women (1000) who underwent a CS in one of the 20 participating hospitals during the study period (3-4 months). All hospitals participate in the Dutch consortium and consist of university teaching-, non-university teaching- and non-university-non-teaching hospitals.
- Barrier analysis: Qualitative: 15-20 professionals and 15-20 patients from the hospitals in the upper and lower extremes of the 'adherence distribution'. Quantitative: obstetricians in the Netherlands and 200 experienced patients.
- CBA study: depending on the outcome of phase 2 and 3 of the study, the implementation strategy will be designed for a target group with low guideline adherence and high incidence.
Description
Inclusion Criteria:
- A previous caesarean section in a 3-4 month time period.
Exclusion Criteria:
- Major congenital malformality
- Fetal death prior to onset of delivery
- Duration of pregnancy less than 24 weeks of gestation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Caesarean section
|
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)
|
Vaginal birth (control)
|
An implementation strategy to improve outcome for women in labour will be developed depending on the outcome of the current care study and the barrier and facilitator analysis.The strategy will be executed and evaluated in a controlled before-and-after study in 12 hospitals (6 intervention, 6 control)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1) Development of quality indicators: development of a valid set of quality indicators for measuring current Dutch care on caesarean sections
Time Frame: December 2010 - October 2013
|
December 2010 - October 2013
|
2) Current care study: The main outcome is the adherence to the quality indicators regarding the process, structure and outcome (maternal and fetal) of care
Time Frame: December 2010 - October 2013
|
December 2010 - October 2013
|
3) Barrier and facilitator analysis: Identification of barriers and facilitators to perform a caesarean section
Time Frame: December 2010 - October 2013
|
December 2010 - October 2013
|
4) Controlled before-and-after study: effectiveness of the implementation strategy defined as observed increase in adherence between the intervention and control hospitals and actual CS rates in both groups
Time Frame: December 2010 - October 2013
|
December 2010 - October 2013
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
1) Development of quality indicators: no secondary outcomes
Time Frame: December 2010 - October 2013
|
December 2010 - October 2013
|
|
2) Current care study: International comparison
Time Frame: December 2010- October 2013
|
Dutch practice as compared to international data (Robson criteria)
|
December 2010- October 2013
|
3) Barrier and facilitator analysis: no secondary outcomes
Time Frame: December 2010-October 2013
|
December 2010-October 2013
|
|
4) Controlled before-and-after study: experiences and satisfaction of health care providers and patients with the implementation strategy and applicability and costs of the strategy
Time Frame: December 2010-October 2013
|
December 2010-October 2013
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hubertina CJ Scheepers, Ph.D., Maastricht University Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 09-4-047
- 17100.3006 (Other Grant/Funding Number: zonMW)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caesarean Section
-
Assiut UniversityUnknownCaesarean SectionEgypt
-
Taipei Medical University WanFang HospitalCompletedCaesarean SectionTaiwan
-
Sintetica SACross Research S.A.TerminatedUnplanned Caesarean SectionBelgium
-
Egyptian Society of Royal College of Obstetricians...UnknownCaesarean Section RateEgypt
-
Shanghai First Maternity and Infant HospitalUnknownCaesarean SectionChina
-
Maimonides Medical CenterTerminatedCaesarean SectionUnited States
-
Minia UniversityCompletedCaesarean Section Rate | EgyptEgypt
-
Trakya UniversityCompletedCaesarean Section | Anesthesia; Reaction
-
Chelsea and Westminster NHS Foundation TrustCompletedCaesarean Section | AnesthesiaUnited Kingdom
Clinical Trials on Implementation aids
-
ZonMw: The Netherlands Organisation for Health...UnknownHemorrhage, PostpartumNetherlands
-
ZonMw: The Netherlands Organisation for Health...Cardiff University; University Medical Center Groningen; Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and other collaboratorsUnknownColorectal Neoplasms, Hereditary Nonpolyposis
-
Yale UniversityNational Institute of Allergy and Infectious Diseases (NIAID); National Heart...CompletedTuberculosis | Tuberculosis, PulmonaryUganda
-
University of PittsburghNational Institute of Mental Health (NIMH)Not yet recruiting
-
Medical University of LodzCompletedChronic Obstructive Pulmonary Disease (COPD)Poland
-
Iowa State UniversityKansas State University; Louisiana State University Health Sciences Center... and other collaboratorsCompletedHealth Promotion | Overweight and Obesity | Sedentary Behavior | Diet, Healthy | Healthy LifestyleUnited States
-
Sonova AGToronto Metropolitan UniversityNot yet recruiting
-
Harvard Medical School (HMS and HSDM)Sangath; Ministry of Health & Family Welfare, IndiaCompletedDepressive Disorder | Depression | Noncommunicable Diseases | PsychologicalIndia
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); Kamuzu University of Health Sciences and other collaboratorsCompleted
-
Boston Medical CenterAgency for Healthcare Research and Quality (AHRQ)Completed